U.S. Markets closed

The Ultralife Share Price Has Gained 166%, So Why Not Pay It Some Attention?

Simply Wall St

The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put in. But on the bright side, if you buy shares in a high quality company at the right price, you can gain well over 100%. For instance, the price of Ultralife Corporation (NASDAQ:ULBI) stock is up an impressive 166% over the last five years. On top of that, the share price is up 45% in about a quarter.

Check out our latest analysis for Ultralife

While the efficient markets hypothesis continues to be taught by some, it has been proven that markets are over-reactive dynamic systems, and investors are not always rational. One flawed but reasonable way to assess how sentiment around a company has changed is to compare the earnings per share (EPS) with the share price.

During the last half decade, Ultralife became profitable. Sometimes, the start of profitability is a major inflection point that can signal fast earnings growth to come, which in turn justifies very strong share price gains. Since the company was unprofitable five years ago, but not three years ago, it’s worth taking a look at the returns in the last three years, too. Indeed, the Ultralife share price has gained 98% in three years. Meanwhile, EPS is up 107% per year. This EPS growth is higher than the 26% average annual increase in the share price over the same three years. So you might conclude the market is a little more cautious about the stock, these days. This unenthusiastic sentiment is reflected in the stock’s reasonably modest P/E ratio of 6.49.

The image below shows how EPS has tracked over time (if you click on the image you can see greater detail).

NasdaqGM:ULBI Past and Future Earnings, March 7th 2019

Dive deeper into Ultralife’s key metrics by checking this interactive graph of Ultralife’s earnings, revenue and cash flow.

A Different Perspective

It’s nice to see that Ultralife shareholders have received a total shareholder return of 33% over the last year. That’s better than the annualised return of 22% over half a decade, implying that the company is doing better recently. In the best case scenario, this may hint at some real business momentum, implying that now could be a great time to delve deeper. Most investors take the time to check the data on insider transactions. You can click here to see if insiders have been buying or selling.

Of course Ultralife may not be the best stock to buy. So you may wish to see this free collection of growth stocks.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on US exchanges.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.